Members Login
Channels
Special Offers & Promotions
FluidiGM Europe
Products
Contact FluidiGM Europe
All articles from FluidiGM Europe
Fluidigm announced an agreement to develop and supply a customized version of its high- throughput library prep system to the DKMS (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) Life Science Lab. The new system will help the DKMS accelerate its research to fight against blood cancer by ultimately enabling it to characterize the HLA genes from several thousand samples a week for its donor registry...
Government officials, academic, and industry leaders gathered to celebrate the official opening of the Single-Cell Omics Centre (SCOC) in Singapore on April 12, 2013. It is the first research centre in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells....
Fluidigm Announces Unrestricted Sales into Prenatal Health and Non-Invasive Prenatal Diagnostics Fields of Research
Jun 14, 2012
This enhanced freedom to operate comes as a result of the ending of the collaboration agreement previously reported in the company's filings with the Securities and Exchange Commission between Fluidigm and Novartis Vaccines & Diagnostics, Inc...
The Single-Cell Genomics Center is also expected to act as a hub for collaboration among single-cell genomics researchers in many pioneering fields, including stem cells and cancer biology. The Center will be housed at the Broad Institute in Cambridge, Massachusetts and will feature a complete suite of Fluidigm single-cell tools, protocols and technologies, most notably the BioMarkTM HD System...
Fluidigm Corporation has announced that Rujin Hospital in Shanghai, China has used the company's integrated fluidic circuits (IFCs) to help validate two new susceptibility loci for Graves' disease. Researchers applied the unique properties of the Fluidigm 96.96 Dynamic Array IFC and the EP1 System to re-genotype selected SNPs for the replication study...
Fluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria III Cell Sorter and analysis using the Fluidigm BioMark HD System.
Fluidigm has added a new genre - customer web videos to the wide array of topical information (publications, application notes, posters, newsletters, press releases) available from its website. Eve Marquis, Marketing Manager of Fluidigm Europe commented "Online video creates a more personal interaction between Fluidigm and our target audience in Single Cell, Gene Expression, SNP Genotyping, Next Generation Sequencing and Copy Number Variation markets...
Fluidigm has announced that the Broad Institute of MIT and Harvard has purchased an Access ArrayTM System to automate its sample preparation for targeted resequencing. The Access Array System enhances the capabilities of powerful next-generation sequencing platforms by allowing the preparation of several sample libraries in parallel...
Fluidigm Corporation has introduced its 192.24 Dynamic ArrayTM IFC, designed to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnology and genome wide association studies...
Fluidigm Corporation has announced the availability of new assays and primers optimized for the company's integrated fluidic circuit technology. Fluidigm Assays and Target-specific Primers will provide customers with significantly lower costs than today's standard solutions, at volumes appropriate for microfluidics, and flexible chemistries so that customers can easily create highly multiplexed panels using off-the-shelf and custom content focused on their particular research area. As part of the program, Fluidigm will provide the assay primer locus sequences with every order...
Fluidigm has announced that its Singapore factory has now manufactured and shipped more than 1 billion microscopic NanoFlexTM valves. Each NanoFlex valve is so small that it takes 10 to span the width of a human hair. The billion valves built into Fluidigm's integrated fluidic circuits (IFCs) are equivalent to the number of valves required for all the conventional plumbing for every home in California, Texas and New York (the three most populous states in the United States of America)...
Fluidigm Europe has announced a new technical report that describes experimentation on a normal human genomic DNA sample using a prototype 200k Digital Array Chip on a modified BioMarkTM System.
Fluidigm has announced that MLL Munich Leukemia Laboratory (www.mll.com) has used the company's Access ArrayTM technology to help it uncover mutations in over 80 percent of chronic myelomonocytic leukemia (CMML) patients, providing new insights into the molecular heterogeneity of the disease. MLL researchers applied the unique properties of the Fluidigm Access Array System to prepare the samples and barcode the amplicons for next-generation deep-sequencing using 454 sequencing technology...
Using Fluidigm Corporation's BioMarkTM System and Digital ArrayTM integrated fluidic circuits (IFCs), researchers from the University of California San Francisco (UCSF)** have identified serum microRNAs that can serve as biomarkers for prostate cancer...
Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Eisenberg Brothers Ltd. as its distributor in Israel. Eisenberg Brothers will offer Fluidigm's complete portfolio of BioMark, EP1, and Access Array Systems and the complete line up of Dynamic Array, Digital Array and Access Array IFCs for real-time PCR, digital PCR, genotyping, gene expression, copy number variation and absolute quantification for sequencing...
Fluidigm has introduced the new BioMarkTM HD Real-time PCR System, the company's most advanced instrument for genomic analysis ever. The BioMark HD System is designed for researchers who require the sensitivity and throughput needed to study gene expression down to the single-cell level -- especially those who have limited amounts of sample or study rare populations of cells.
Fluidigm has launched a new comprehensively featured website designed to offer a wide variety of useful information to life science organisations involved with gene expression, single cell research, SNP genotyping, target resequencing, NGS sample preparation and determination of copy number variation.
Available from Fluidigm Europe - a recent independent feature in Technology Review Magazine calls Fluidigm's technology "a fundamental breakthrough in how researchers can interact with the biological world".
Fluidigm Corporation has announced that MLL Munich Leukemia Laboratory has purchased Access ArrayTM and EP1TM Systems. The Access Array System is being used in combination with Roche's 454 GS FLX and GS Junior sequencing instruments, enabling high-throughput targeted deep-resequencing analyses. The EP1 System is being used for rare mutation detection studies and minimal residual disease investigations.
Fluidigm Europe has announced an opportunity for scientists to learn more about how the Fluidigm Access ArrayTM System is being used by the US National Cancer Institute to explore genetic diversity and how to effectively implement techniques for next generation sequencing.
Fluidigm Corporation has announced that the Fall 2010 edition of its community newsletter is now available free to download. The Fluidigm Community Newsletter is a quarterly publication dedicated to providing you with the most recent research, product updates, and news featuring Fluidigm Integrated Fluidic Circuit (IFC) technology
Single Cell Expression Data Offers Detailed Molecular Understanding Of Embryonic Development
May 6, 2010
Fluidigm & IntegraGen Join Forces To Create A Genetic Analysis Service And European Demonstartion Facility
Feb 5, 2010
Media Partners